Vascular and Surgery

Category icon
Intraventricular Conduction Disturbances After TAVI

Shu-I Lin, Mizuki Miura, Ana Paula Tagliari, et al

Category icon
Management of Valvular Disease During Pregnancy

Chiara Fraccaro, Noemie Tence, Giulia Masiero, et al

Category icon
Treating Mitral Regurgitation in the Wake of COAPT

Kelly H Schlendorf, Jared O’Leary, JoAnn Lindenfeld,

Category icon
Chimney Stenting in TAVI

Liesbeth Rosseel, Michael Rosseel, Brian G Hynes, et al

Category icon
Contemporary Management of Secondary Mitral Regurgitation

Kashish Goel, Colin M Barker, JoAnn Lindenfeld,

Category icon
Destination Therapy with LVAD in Non-transplant Centres

Antoni Bayés-Genís, Christian Muñoz-Guijosa, Evelyn Santiago-Vacas, et al

Category icon
Interatrial Shunting for Left Heart Failure

Leonardo Guimaraes, David del Val, Sebastien Bergeron, et al

Category icon
Anticoagulation after TAVI

Antonio Greco, Davide Capodanno,

Category icon
Antithrombotic Therapy After TAVI

Leslie Marisol Lugo, Rafael Romaguera, Joan Antoni Gómez-Hospital, et al

Category icon
Will Direct Oral Anticoagulants Have a Chance in Prosthetic Valves?

Mahmoud Abdelnabi, Abdallah Almaghraby, Yehia Saleh,

About

Heart transplantation surgery has become the standard treatment for selected patients with end-stage heart failure. Improvements in immunosuppressant, donor procurement, surgical techniques, and post-transplant care have resulted in a substantial decrease in acute allograft rejection, which had previously significantly limited survival of heart transplant recipients.

The number of heart transplants performed worldwide over the last decade has continued to increase annually.

Current challenges include older age of both recipients and donors; an increasing number of transplants performed with mechanical circulatory support; the growing use of combined organ transplants (now more than 4% of all heart transplants); and a high proportion of sensitised patients (those with pre-formed antibodies against human leukocyte antigens, which increased the risk of organ rejection).

Related Articles

Articles

Intraventricular Conduction Disturbances After TAVI

Shu-I Lin, Mizuki Miura, Ana Paula Tagliari,

Published:

Citation: Interventional Cardiology Review 2020;15:e11.

Management of Valvular Disease During Pregnancy

Chiara Fraccaro, Noemie Tence, Giulia Masiero,

Published:

Citation: Interventional Cardiology Review 2020;15:e10.

Treating Mitral Regurgitation in the Wake of COAPT

Kelly H Schlendorf, Jared O’Leary, JoAnn Lindenfeld,

Published:

Citation: US Cardiology Review 2020;14:e06.

Chimney Stenting in TAVI

Liesbeth Rosseel, Michael Rosseel, Brian G Hynes,

Published:

Citation: Interventional Cardiology Review 2020;15:e09.